Schonfeld Strategic Advisors LLC Obs Eva Sa Transaction History

Schonfeld Strategic Advisors LLC

  • $14.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$1.89 - $2.55 $86,562 - $116,789
-45,800 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$2.46 - $6.15 $112,668 - $281,670
45,800 New
45,800 $0
Q3 2018

Nov 14, 2018
SELL
$10.92 - $18.18 $202,566 - $337,239
-18,550 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$10.0 - $17.87 $185,500 - $331,488
18,550 New
18,550 $281,000

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email